Zemplar

Paricalcitol (Zemplar) is a vitamin D analog prescribed to manage secondary hyperparathyroidism in chronic kidney disease. This oral medication helps regulate calcium and phosphorus levels. Suitable for adults and pediatric patients 10+ when prescribed. Short version: Paricalcitol (Zemplar) oral medication for secondary hyperparathyroidism in chronic kidney disease, regulating calcium and phosphorus levels in adults and children 10+.

Paricalcitol is used to treat secondary hyperparathyroidism in patients with chronic kidney disease, particularly those on dialysis. It helps lower elevated parathyroid hormone levels while supporting balanced calcium and phosphorus metabolism. The medication is designed to reduce bone complications linked to kidney disease. Patients often ask, 'What is paricalcitol used for?' to manage this condition under medical supervision.

Paricalcitol works by mimicking the action of vitamin D, helping the body absorb calcium and regulate phosphorus levels. Users may notice improved energy levels and reduced bone discomfort over time. Some report mild gastrointestinal effects like nausea or constipation during initial use. Effects vary by individual and should be monitored by a healthcare provider.

Store paricalcitol at room temperature away from moisture and heat. Keep out of reach of children and pets. Avoid crushing or splitting capsules unless directed by a healthcare professional. Inform your doctor about all medications and supplements you take before starting paricalcitol. Regular blood tests may be needed to monitor calcium and phosphorus levels.

Paricalcitol may interact with other vitamin D supplements, calcium-based medications, or phosphate binders. Cholestyramine and certain antacids can reduce its absorption. Strong CYP3A inhibitors may increase paricalcitol levels, while enzyme inducers like rifampin can decrease effectiveness. Always consult a healthcare provider before combining paricalcitol with other drugs.